Nektar Therapeutics buy BiotechBee
Start price
14.09.25
/
70%
€40.80
Target price
28.11.27
€100.00
Performance (%)
-0.49%
End price
15.09.25
€40.60
Summary
This prediction ended on 15.09.25 with a price of €40.60. During the runtime of the prediction for Nektar Therapeutics the price only changed by -0.49%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Nektar Therapeutics | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to BiotechBee what are the pros and cons of Nektar Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Nektar Therapeutics diskutieren
Buy mit Kursziel 100,0